Physician profile
Corinne Bream
NPI 1053468439
$4,612.83
in general payments reported to CMS, 2019-2025
15 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $1,747 · 2021: $808 · 2022: $739 · 2023: $432 · 2024: $276 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,498.86 | 2019-2024 | Myday Contact Lens |
| Alcon Vision LLC | $559.89 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $503.89 | 2019-2024 | Acuvue |
| Glaukos Corporation | $401.82 | 2021-2023 | Kxl System (Refurbished), Kxl1b-Ce-Marked Kxlsystem |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $401.67 | 2019-2021 | |
| Nova Eye, INC. | $229.66 | 2025 | |
| Bausch & Lomb Americas INC. | $189.58 | 2022-2024 | Miebo, Xiidra, Infuse |
| Visionix USA, INC | $131.58 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $117.40 | 2022 | |
| New World Medical,INC. | $116.34 | 2022 | |
| Biotissue Holdings INC. | $101.10 | 2020-2022 | |
| Rxsight INC | $100.22 | 2020 | |
| Abbvie INC. | $89.63 | 2023 | Vuity |
| Novartis Pharmaceuticals Corporation | $87.43 | 2019-2022 | |
| Optos, INC. | $83.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinne Bream listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.